Los Angeles Capital Management
ATRS

Los Angeles Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Los Angeles Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-183,440
Closed -$732K – 1680
2020
Q4 		$732K Sell
183,440
-4,950
-3% -$16K ﹤0.01% 1061
2020
Q3 		$509K Buy
188,390
+6,050
+3% +$16.7K ﹤0.01% 1075
2020
Q2 		$501K Buy
182,340
+101,600
+126% +$283K ﹤0.01% 1108
2020
Q1 		$191K Buy
+80,740
New +$275K ﹤0.01% 1189

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Los Angeles Capital Management's ATRS Position: Q1 2021 in Review

Los Angeles Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 183,440 shares — an estimated $732K sold.

Los Angeles Capital Management first reported a position in ATRS in Q1 2020 and held it in 4 quarters. The position peaked at $732K in Q4 2020. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

  • Los Angeles Capital Management reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 183,440 Antares Pharma, Inc. shares in Q1 2021, an estimated $732K.
  • Los Angeles Capital Management first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 4 quarters.
  • Los Angeles Capital Management's Antares Pharma, Inc. position peaked at $732K in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on Los Angeles Capital Management's 13F filing for Q1 2021, filed 5 May 2021.